Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Growth (Status and Outlook) 2025-2031

December 2025 | 73 pages | ID: GC07AD840D8FEN
LP Information

Abstracts

According to this study, the global Epidermal Growth Factor Receptor (EGFR) Inhibitor market size will reach US$ million by 2031.

The epidermal growth factor receptor (EGFR; ErbB-1; HER1 in humans) is a transmembrane protein that is a receptor for members of the epidermal growth factor family (EGF family) of extracellular protein ligands.

The high efficacy of EGFR inhibitors in the treatment of various types of cancer indications has encouraged researchers to study its use in the treatment of inflammatory and monogenic diseases. Recent in-vitro research studies have suggested that EGFR mutations may cause indications such as eczema, psoriasis, and atherosclerosis. Although these studies are in the early stages of clinical trials, the huge unmet need and further advancements in research are expected to brighten the growth prospects of EGFR inhibitors market vendors in new research areas.

LPI (LP Information)' newest research report, the “Epidermal Growth Factor Receptor (EGFR) Inhibitor Industry Forecast” looks at past sales and reviews total world Epidermal Growth Factor Receptor (EGFR) Inhibitor sales in 2024, providing a comprehensive analysis by region and market sector of projected Epidermal Growth Factor Receptor (EGFR) Inhibitor sales for 2025 through 2031. With Epidermal Growth Factor Receptor (EGFR) Inhibitor sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Epidermal Growth Factor Receptor (EGFR) Inhibitor industry.

This Insight Report provides a comprehensive analysis of the global Epidermal Growth Factor Receptor (EGFR) Inhibitor landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Epidermal Growth Factor Receptor (EGFR) Inhibitor portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Epidermal Growth Factor Receptor (EGFR) Inhibitor market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Epidermal Growth Factor Receptor (EGFR) Inhibitor and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Epidermal Growth Factor Receptor (EGFR) Inhibitor.

This report presents a comprehensive overview, market shares, and growth opportunities of Epidermal Growth Factor Receptor (EGFR) Inhibitor market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Lung Cancer
• Colorectal Cancer
• Breast Cancer
• Others

Segmentation by Application:

• Hospital
• Research Institutes and Research Institutions
• Clinic
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Amgen Inc.
• AstraZeneca Plc
• Eli Lilly and Co.
• F. Hoffmann-La Roche Ltd.
• Novartis AG

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size (2020-2031)
  2.1.2 Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Epidermal Growth Factor Receptor (EGFR) Inhibitor by Country/Region (2020, 2024 & 2031)
2.2 Epidermal Growth Factor Receptor (EGFR) Inhibitor Segment by Type
  2.2.1 Lung Cancer
  2.2.2 Colorectal Cancer
  2.2.3 Breast Cancer
  2.2.4 Others
2.3 Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type
  2.3.1 Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Market Share by Type (2020-2025)
2.4 Epidermal Growth Factor Receptor (EGFR) Inhibitor Segment by Application
  2.4.1 Hospital
  2.4.2 Research Institutes and Research Institutions
  2.4.3 Clinic
  2.4.4 Other
2.5 Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application
  2.5.1 Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Market Share by Application (2020-2025)

3 EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) INHIBITOR MARKET SIZE BY PLAYER

3.1 Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Market Share by Player
  3.1.1 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue by Player (2020-2025)
  3.1.2 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue Market Share by Player (2020-2025)
3.2 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) INHIBITOR BY REGION

4.1 Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Region (2020-2025)
4.2 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Annual Revenue by Country/Region (2020-2025)
4.3 Americas Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Growth (2020-2025)
4.4 APAC Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Growth (2020-2025)
4.5 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Growth (2020-2025)
4.6 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country (2020-2025)
5.2 Americas Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2020-2025)
5.3 Americas Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Region (2020-2025)
6.2 APAC Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2020-2025)
6.3 APAC Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country (2020-2025)
7.2 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2020-2025)
7.3 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor by Region (2020-2025)
8.2 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2020-2025)
8.3 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) INHIBITOR MARKET FORECAST

10.1 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Forecast by Region (2026-2031)
  10.1.1 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Forecast by Region (2026-2031)
  10.1.2 Americas Epidermal Growth Factor Receptor (EGFR) Inhibitor Forecast
  10.1.3 APAC Epidermal Growth Factor Receptor (EGFR) Inhibitor Forecast
  10.1.4 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Forecast
  10.1.5 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Forecast
10.2 Americas Epidermal Growth Factor Receptor (EGFR) Inhibitor Forecast by Country (2026-2031)
  10.2.1 United States Market Epidermal Growth Factor Receptor (EGFR) Inhibitor Forecast
  10.2.2 Canada Market Epidermal Growth Factor Receptor (EGFR) Inhibitor Forecast
  10.2.3 Mexico Market Epidermal Growth Factor Receptor (EGFR) Inhibitor Forecast
  10.2.4 Brazil Market Epidermal Growth Factor Receptor (EGFR) Inhibitor Forecast
10.3 APAC Epidermal Growth Factor Receptor (EGFR) Inhibitor Forecast by Region (2026-2031)
  10.3.1 China Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Forecast
  10.3.2 Japan Market Epidermal Growth Factor Receptor (EGFR) Inhibitor Forecast
  10.3.3 Korea Market Epidermal Growth Factor Receptor (EGFR) Inhibitor Forecast
  10.3.4 Southeast Asia Market Epidermal Growth Factor Receptor (EGFR) Inhibitor Forecast
  10.3.5 India Market Epidermal Growth Factor Receptor (EGFR) Inhibitor Forecast
  10.3.6 Australia Market Epidermal Growth Factor Receptor (EGFR) Inhibitor Forecast
10.4 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Forecast by Country (2026-2031)
  10.4.1 Germany Market Epidermal Growth Factor Receptor (EGFR) Inhibitor Forecast
  10.4.2 France Market Epidermal Growth Factor Receptor (EGFR) Inhibitor Forecast
  10.4.3 UK Market Epidermal Growth Factor Receptor (EGFR) Inhibitor Forecast
  10.4.4 Italy Market Epidermal Growth Factor Receptor (EGFR) Inhibitor Forecast
  10.4.5 Russia Market Epidermal Growth Factor Receptor (EGFR) Inhibitor Forecast
10.5 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Forecast by Region (2026-2031)
  10.5.1 Egypt Market Epidermal Growth Factor Receptor (EGFR) Inhibitor Forecast
  10.5.2 South Africa Market Epidermal Growth Factor Receptor (EGFR) Inhibitor Forecast
  10.5.3 Israel Market Epidermal Growth Factor Receptor (EGFR) Inhibitor Forecast
  10.5.4 Turkey Market Epidermal Growth Factor Receptor (EGFR) Inhibitor Forecast
10.6 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Forecast by Type (2026-2031)
10.7 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Epidermal Growth Factor Receptor (EGFR) Inhibitor Forecast

11 KEY PLAYERS ANALYSIS

11.1 Amgen Inc.
  11.1.1 Amgen Inc. Company Information
  11.1.2 Amgen Inc. Epidermal Growth Factor Receptor (EGFR) Inhibitor Product Offered
  11.1.3 Amgen Inc. Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Amgen Inc. Main Business Overview
  11.1.5 Amgen Inc. Latest Developments
11.2 AstraZeneca Plc
  11.2.1 AstraZeneca Plc Company Information
  11.2.2 AstraZeneca Plc Epidermal Growth Factor Receptor (EGFR) Inhibitor Product Offered
  11.2.3 AstraZeneca Plc Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 AstraZeneca Plc Main Business Overview
  11.2.5 AstraZeneca Plc Latest Developments
11.3 Eli Lilly and Co.
  11.3.1 Eli Lilly and Co. Company Information
  11.3.2 Eli Lilly and Co. Epidermal Growth Factor Receptor (EGFR) Inhibitor Product Offered
  11.3.3 Eli Lilly and Co. Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Eli Lilly and Co. Main Business Overview
  11.3.5 Eli Lilly and Co. Latest Developments
11.4 F. Hoffmann-La Roche Ltd.
  11.4.1 F. Hoffmann-La Roche Ltd. Company Information
  11.4.2 F. Hoffmann-La Roche Ltd. Epidermal Growth Factor Receptor (EGFR) Inhibitor Product Offered
  11.4.3 F. Hoffmann-La Roche Ltd. Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 F. Hoffmann-La Roche Ltd. Main Business Overview
  11.4.5 F. Hoffmann-La Roche Ltd. Latest Developments
11.5 Novartis AG
  11.5.1 Novartis AG Company Information
  11.5.2 Novartis AG Epidermal Growth Factor Receptor (EGFR) Inhibitor Product Offered
  11.5.3 Novartis AG Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Novartis AG Main Business Overview
  11.5.5 Novartis AG Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Epidermal Growth Factor Receptor (EGFR) Inhibitor Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Lung Cancer
Table 4. Major Players of Colorectal Cancer
Table 5. Major Players of Breast Cancer
Table 6. Major Players of Others
Table 7. Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 8. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2020-2025) & ($ millions)
Table 9. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Market Share by Type (2020-2025)
Table 10. Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 11. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2020-2025) & ($ millions)
Table 12. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Market Share by Application (2020-2025)
Table 13. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue by Player (2020-2025) & ($ millions)
Table 14. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue Market Share by Player (2020-2025)
Table 15. Epidermal Growth Factor Receptor (EGFR) Inhibitor Key Players Head office and Products Offered
Table 16. Epidermal Growth Factor Receptor (EGFR) Inhibitor Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Region (2020-2025) & ($ millions)
Table 20. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Market Share by Region (2020-2025)
Table 21. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue by Country/Region (2020-2025) & ($ millions)
Table 22. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue Market Share by Country/Region (2020-2025)
Table 23. Americas Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country (2020-2025) & ($ millions)
Table 24. Americas Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Market Share by Country (2020-2025)
Table 25. Americas Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2020-2025) & ($ millions)
Table 26. Americas Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Market Share by Type (2020-2025)
Table 27. Americas Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2020-2025) & ($ millions)
Table 28. Americas Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Market Share by Application (2020-2025)
Table 29. APAC Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Region (2020-2025) & ($ millions)
Table 30. APAC Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Market Share by Region (2020-2025)
Table 31. APAC Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2020-2025) & ($ millions)
Table 32. APAC Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2020-2025) & ($ millions)
Table 33. Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country (2020-2025) & ($ millions)
Table 34. Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Market Share by Country (2020-2025)
Table 35. Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2020-2025) & ($ millions)
Table 36. Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2020-2025) & ($ millions)
Table 37. Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Region (2020-2025) & ($ millions)
Table 38. Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2020-2025) & ($ millions)
Table 39. Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2020-2025) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Epidermal Growth Factor Receptor (EGFR) Inhibitor
Table 41. Key Market Challenges & Risks of Epidermal Growth Factor Receptor (EGFR) Inhibitor
Table 42. Key Industry Trends of Epidermal Growth Factor Receptor (EGFR) Inhibitor
Table 43. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Forecast by Region (2026-2031) & ($ millions)
Table 44. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Market Share Forecast by Region (2026-2031)
Table 45. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Forecast by Type (2026-2031) & ($ millions)
Table 46. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Forecast by Application (2026-2031) & ($ millions)
Table 47. Amgen Inc. Details, Company Type, Epidermal Growth Factor Receptor (EGFR) Inhibitor Area Served and Its Competitors
Table 48. Amgen Inc. Epidermal Growth Factor Receptor (EGFR) Inhibitor Product Offered
Table 49. Amgen Inc. Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 50. Amgen Inc. Main Business
Table 51. Amgen Inc. Latest Developments
Table 52. AstraZeneca Plc Details, Company Type, Epidermal Growth Factor Receptor (EGFR) Inhibitor Area Served and Its Competitors
Table 53. AstraZeneca Plc Epidermal Growth Factor Receptor (EGFR) Inhibitor Product Offered
Table 54. AstraZeneca Plc Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 55. AstraZeneca Plc Main Business
Table 56. AstraZeneca Plc Latest Developments
Table 57. Eli Lilly and Co. Details, Company Type, Epidermal Growth Factor Receptor (EGFR) Inhibitor Area Served and Its Competitors
Table 58. Eli Lilly and Co. Epidermal Growth Factor Receptor (EGFR) Inhibitor Product Offered
Table 59. Eli Lilly and Co. Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 60. Eli Lilly and Co. Main Business
Table 61. Eli Lilly and Co. Latest Developments
Table 62. F. Hoffmann-La Roche Ltd. Details, Company Type, Epidermal Growth Factor Receptor (EGFR) Inhibitor Area Served and Its Competitors
Table 63. F. Hoffmann-La Roche Ltd. Epidermal Growth Factor Receptor (EGFR) Inhibitor Product Offered
Table 64. F. Hoffmann-La Roche Ltd. Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 65. F. Hoffmann-La Roche Ltd. Main Business
Table 66. F. Hoffmann-La Roche Ltd. Latest Developments
Table 67. Novartis AG Details, Company Type, Epidermal Growth Factor Receptor (EGFR) Inhibitor Area Served and Its Competitors
Table 68. Novartis AG Epidermal Growth Factor Receptor (EGFR) Inhibitor Product Offered
Table 69. Novartis AG Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 70. Novartis AG Main Business
Table 71. Novartis AG Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Epidermal Growth Factor Receptor (EGFR) Inhibitor Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Epidermal Growth Factor Receptor (EGFR) Inhibitor Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Epidermal Growth Factor Receptor (EGFR) Inhibitor Sales Market Share by Country/Region (2024)
Figure 8. Epidermal Growth Factor Receptor (EGFR) Inhibitor Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Market Share by Type in 2024
Figure 10. Epidermal Growth Factor Receptor (EGFR) Inhibitor in Hospital
Figure 11. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market: Hospital (2020-2025) & ($ millions)
Figure 12. Epidermal Growth Factor Receptor (EGFR) Inhibitor in Research Institutes and Research Institutions
Figure 13. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market: Research Institutes and Research Institutions (2020-2025) & ($ millions)
Figure 14. Epidermal Growth Factor Receptor (EGFR) Inhibitor in Clinic
Figure 15. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market: Clinic (2020-2025) & ($ millions)
Figure 16. Epidermal Growth Factor Receptor (EGFR) Inhibitor in Other
Figure 17. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market: Other (2020-2025) & ($ millions)
Figure 18. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Market Share by Application in 2024
Figure 19. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue Market Share by Player in 2024
Figure 20. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Market Share by Region (2020-2025)
Figure 21. Americas Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size 2020-2025 ($ millions)
Figure 22. APAC Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size 2020-2025 ($ millions)
Figure 23. Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size 2020-2025 ($ millions)
Figure 24. Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size 2020-2025 ($ millions)
Figure 25. Americas Epidermal Growth Factor Receptor (EGFR) Inhibitor Value Market Share by Country in 2024
Figure 26. United States Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 27. Canada Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 28. Mexico Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 29. Brazil Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 30. APAC Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Market Share by Region in 2024
Figure 31. APAC Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Market Share by Type (2020-2025)
Figure 32. APAC Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Market Share by Application (2020-2025)
Figure 33. China Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 34. Japan Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 35. South Korea Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 36. Southeast Asia Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 37. India Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 38. Australia Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 39. Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Market Share by Country in 2024
Figure 40. Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Market Share by Type (2020-2025)
Figure 41. Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Market Share by Application (2020-2025)
Figure 42. Germany Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 43. France Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 44. UK Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 45. Italy Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 46. Russia Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 47. Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Market Share by Region (2020-2025)
Figure 48. Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Market Share by Type (2020-2025)
Figure 49. Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Market Share by Application (2020-2025)
Figure 50. Egypt Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 51. South Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 52. Israel Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 53. Turkey Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 54. GCC Countries Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 55. Americas Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size 2026-2031 ($ millions)
Figure 56. APAC Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size 2026-2031 ($ millions)
Figure 57. Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size 2026-2031 ($ millions)
Figure 58. Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size 2026-2031 ($ millions)
Figure 59. United States Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size 2026-2031 ($ millions)
Figure 60. Canada Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size 2026-2031 ($ millions)
Figure 61. Mexico Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size 2026-2031 ($ millions)
Figure 62. Brazil Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size 2026-2031 ($ millions)
Figure 63. China Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size 2026-2031 ($ millions)
Figure 64. Japan Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size 2026-2031 ($ millions)
Figure 65. Korea Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size 2026-2031 ($ millions)
Figure 66. Southeast Asia Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size 2026-2031 ($ millions)
Figure 67. India Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size 2026-2031 ($ millions)
Figure 68. Australia Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size 2026-2031 ($ millions)
Figure 69. Germany Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size 2026-2031 ($ millions)
Figure 70. France Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size 2026-2031 ($ millions)
Figure 71. UK Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size 2026-2031 ($ millions)
Figure 72. Italy Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size 2026-2031 ($ millions)
Figure 73. Russia Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size 2026-2031 ($ millions)
Figure 74. Egypt Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size 2026-2031 ($ millions)
Figure 75. South Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size 2026-2031 ($ millions)
Figure 76. Israel Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size 2026-2031 ($ millions)
Figure 77. Turkey Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size 2026-2031 ($ millions)
Figure 78. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Market Share Forecast by Type (2026-2031)
Figure 79. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Market Share Forecast by Application (2026-2031)
Figure 80. GCC Countries Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size 2026-2031 ($ millions)